A detailed history of Nemes Rush Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Nemes Rush Group LLC holds 154 shares of BSX stock, worth $14,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 154 -0.0%
Holding current value
$14,024
Previous $11.9 Million 11.07%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$67.33 - $77.71 $41,273 - $47,636
-613 Reduced 79.92%
154 $11.9 Million
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $7,729 - $8,420
154 Added 25.12%
767 $40.5 Million
Q2 2023

Aug 02, 2023

BUY
$49.72 - $54.64 $30,478 - $33,494
613 New
613 $33.2 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.